Genomic Vision (Germany) Market Value
| G09 Stock | EUR 706.78 0.59 0.08% |
| Symbol | Genomic |
Genomic Vision 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genomic Vision's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genomic Vision.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Genomic Vision on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Genomic Vision Socit or generate 0.0% return on investment in Genomic Vision over 30 days. Genomic Vision is related to or competes with Salesforce, CARSALES, BOS BETTER, Carsales, Canon Marketing, PACIFIC ONLINE, and SALESFORCE INC. Genomic Vision Socit Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA d... More
Genomic Vision Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genomic Vision's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genomic Vision Socit upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.19 | |||
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 6.91 | |||
| Value At Risk | (1.42) | |||
| Potential Upside | 2.15 |
Genomic Vision Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genomic Vision's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genomic Vision's standard deviation. In reality, there are many statistical measures that can use Genomic Vision historical prices to predict the future Genomic Vision's volatility.| Risk Adjusted Performance | 0.0253 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | (0.09) | |||
| Treynor Ratio | 0.0867 |
Genomic Vision Socit Backtested Returns
At this point, Genomic Vision is very steady. Genomic Vision Socit holds Efficiency (Sharpe) Ratio of 0.0376, which attests that the entity had a 0.0376% return per unit of risk over the last 3 months. We have found thirty technical indicators for Genomic Vision Socit, which you can use to evaluate the volatility of the firm. Please check out Genomic Vision's Risk Adjusted Performance of 0.0253, downside deviation of 1.19, and Market Risk Adjusted Performance of 0.0967 to validate if the risk estimate we provide is consistent with the expected return of 0.044%. Genomic Vision has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.27, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Genomic Vision's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genomic Vision is expected to be smaller as well. Genomic Vision Socit right now retains a risk of 1.17%. Please check out Genomic Vision total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Genomic Vision will be following its current trending patterns.
Auto-correlation | 0.66 |
Good predictability
Genomic Vision Socit has good predictability. Overlapping area represents the amount of predictability between Genomic Vision time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genomic Vision Socit price movement. The serial correlation of 0.66 indicates that around 66.0% of current Genomic Vision price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.8 | |
| Residual Average | 0.0 | |
| Price Variance | 22.61 |
Genomic Vision Socit lagged returns against current returns
Autocorrelation, which is Genomic Vision stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genomic Vision's stock expected returns. We can calculate the autocorrelation of Genomic Vision returns to help us make a trade decision. For example, suppose you find that Genomic Vision has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Genomic Vision regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genomic Vision stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genomic Vision stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genomic Vision stock over time.
Current vs Lagged Prices |
| Timeline |
Genomic Vision Lagged Returns
When evaluating Genomic Vision's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genomic Vision stock have on its future price. Genomic Vision autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genomic Vision autocorrelation shows the relationship between Genomic Vision stock current value and its past values and can show if there is a momentum factor associated with investing in Genomic Vision Socit.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Genomic Stock
Genomic Vision financial ratios help investors to determine whether Genomic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genomic with respect to the benefits of owning Genomic Vision security.